1. Home
  2. EPSN vs DTIL Comparison

EPSN vs DTIL Comparison

Compare EPSN & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

SELL

Current Price

$5.92

Market Cap

187.2M

Sector

Energy

ML Signal

SELL

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

SELL

Current Price

$6.48

Market Cap

197.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EPSN
DTIL
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.2M
197.9M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
EPSN
DTIL
Price
$5.92
$6.48
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $29.40
AVG Volume (30 Days)
110.8K
★ 251.1K
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 4.20%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.26
N/A
Revenue
N/A
★ $1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.96
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$3.53
52 Week High
$6.65
$9.62

Technical Indicators

Market Signals
Indicator
EPSN
DTIL
Relative Strength Index (RSI) 48.70 44.63
Support Level $5.87 $6.00
Resistance Level $5.97 $7.55
Average True Range (ATR) 0.20 0.35
MACD -0.00 0.07
Stochastic Oscillator 52.94 40.59

Price Performance

Historical Comparison
EPSN
DTIL

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: